Zymeworks (ZYME) Cash & Equivalents (2021 - 2026)
Zymeworks' Cash & Equivalents was $179.41 million in Q2 2026, up 82.6% from $98.25 million a year earlier but down 26.6% from the prior quarter.
Powered by 
Analysis
Zymeworks (ZYME) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Zymeworks came in at $41.16 million, down 37.7% from FY2024.
- Cash & Equivalents has now declined for three consecutive years, with a four-year compound annual growth rate of -32.8% (FY2021 to FY2025).
- In earlier years, Cash & Equivalents was $66.1 million in FY2024 (-58.0%), $157.56 million in FY2023 (-60.7%), $400.91 million in FY2022 (+98.6%) and $201.87 million in FY2021.
- Quarterly Cash & Equivalents has moved between $41.16 million (Q4 2025) and $400.91 million (Q4 2022) over five years.
- Compared with a year earlier, Cash & Equivalents was higher in four of the last eight quarters, with growth averaging 24.4%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q1 2026 (growth of 220.6%); the worst was Q4 2023 (a decline of 60.7%).
- Per Business Quant data, ZYME's Cash & Equivalents in the three quarters before Q2 2026 was $244.28 million (Q1 2026), $41.16 million (Q4 2025) and $64.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Zymeworks | 1.89 Bn | 775.55 Mn | - | 179.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 179.41 Mn |
| Mar 31, 2026 | 244.28 Mn |
| Dec 31, 2025 | 41.16 Mn |
| Sep 30, 2025 | 64.83 Mn |
| Jun 30, 2025 | 98.25 Mn |
| Mar 31, 2025 | 76.20 Mn |
| Dec 31, 2024 | 66.10 Mn |
| Sep 30, 2024 | 122.36 Mn |
| Jun 30, 2024 | 70.96 Mn |
| Mar 31, 2024 | 114.81 Mn |
| Dec 31, 2023 | 157.56 Mn |
| Sep 30, 2023 | 94.33 Mn |
| Jun 30, 2023 | 142.10 Mn |
| Mar 31, 2023 | 181.58 Mn |
| Dec 31, 2022 | 400.91 Mn |
| Sep 30, 2022 | 96.08 Mn |
| Dec 31, 2021 | 201.87 Mn |
API Access
Zymeworks Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ZYME&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ZYME", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ZYME&period=max&api_key=YOUR_API_KEY");
const data = await res.json();